X-100296489-G-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001184880.2(PCDH19):​c.3235C>G​(p.Pro1079Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,209,262 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1079T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., 10 hem., cov: 22)
Exomes 𝑓: 0.000073 ( 0 hom. 24 hem. )

Consequence

PCDH19
NM_001184880.2 missense

Scores

1
3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.37

Publications

2 publications found
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
PCDH19 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 9
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 107 curated pathogenic missense variants (we use a threshold of 10). The gene has 20 curated benign missense variants. Gene score misZ: 2.5929 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Dravet syndrome, developmental and epileptic encephalopathy, 9, X-linked complex neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.012738019).
BP6
Variant X-100296489-G-C is Benign according to our data. Variant chrX-100296489-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93674.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000494 (55/111240) while in subpopulation AFR AF = 0.00167 (51/30561). AF 95% confidence interval is 0.0013. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 55 AD,XL,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH19NM_001184880.2 linkc.3235C>G p.Pro1079Ala missense_variant Exon 6 of 6 ENST00000373034.8 NP_001171809.1
PCDH19NM_001105243.2 linkc.3094C>G p.Pro1032Ala missense_variant Exon 5 of 5 NP_001098713.1
PCDH19NM_020766.3 linkc.3091C>G p.Pro1031Ala missense_variant Exon 5 of 5 NP_065817.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkc.3235C>G p.Pro1079Ala missense_variant Exon 6 of 6 1 NM_001184880.2 ENSP00000362125.4
PCDH19ENST00000255531.8 linkc.3094C>G p.Pro1032Ala missense_variant Exon 5 of 5 1 ENSP00000255531.7
PCDH19ENST00000420881.6 linkc.3091C>G p.Pro1031Ala missense_variant Exon 5 of 5 1 ENSP00000400327.2
PCDH19ENST00000464981.1 linkn.-189C>G upstream_gene_variant 3 ENSP00000479805.1

Frequencies

GnomAD3 genomes
AF:
0.000495
AC:
55
AN:
111187
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00167
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000182
AC:
33
AN:
181383
AF XY:
0.000178
show subpopulations
Gnomad AFR exome
AF:
0.00121
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000961
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000224
GnomAD4 exome
AF:
0.0000729
AC:
80
AN:
1098022
Hom.:
0
Cov.:
30
AF XY:
0.0000660
AC XY:
24
AN XY:
363378
show subpopulations
African (AFR)
AF:
0.00133
AC:
35
AN:
26394
American (AMR)
AF:
0.000170
AC:
6
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.000662
AC:
20
AN:
30203
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54141
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40520
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4134
European-Non Finnish (NFE)
AF:
0.0000143
AC:
12
AN:
841947
Other (OTH)
AF:
0.000130
AC:
6
AN:
46090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000494
AC:
55
AN:
111240
Hom.:
0
Cov.:
22
AF XY:
0.000299
AC XY:
10
AN XY:
33428
show subpopulations
African (AFR)
AF:
0.00167
AC:
51
AN:
30561
American (AMR)
AF:
0.000190
AC:
2
AN:
10531
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3526
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2554
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5972
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
53033
Other (OTH)
AF:
0.00
AC:
0
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000252
Hom.:
0
Bravo
AF:
0.000669
ESP6500AA
AF:
0.00138
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000182
AC:
22

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 16, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 26, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

PCDH19-related disorder Benign:1
Jul 05, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Feb 24, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 9 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
19
DANN
Benign
0.96
DEOGEN2
Benign
0.085
.;T;.
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.81
T;T;T
M_CAP
Pathogenic
0.47
D
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
.;N;.
PhyloP100
3.4
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.2
N;N;N
REVEL
Benign
0.025
Sift
Uncertain
0.018
D;D;D
Sift4G
Benign
0.14
T;T;T
Polyphen
0.24, 0.0010
.;B;B
Vest4
0.15
MVP
0.52
MPC
0.49
ClinPred
0.012
T
GERP RS
4.9
Varity_R
0.10
gMVP
0.27
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200854927; hg19: chrX-99551487; API